Sakamakon bincike na pepioid pepides daga yarda na frifelikefalin

Tun da wuri 2021-08-24, CARA CAALAPEICICICICICE DA MAGANARSA NA FDAPPa Opassiad Reparlikafalin cutar 2022Q1. CARA da VIGOR sun sanya hannu kan yarjejeniyar lasisi na musamman ga kasuwancin Korsuva ™ a Amurka kuma sun amince da sayar da Korsuva ™ zuwa Mediseus na likita. Daga gare su, CARA da Vifor kowannensu yana da 60% da kashi 40% na riba a cikin kudaden shiga na tallace-tallace wanin banda freshenius likita; Kowannensu yana da ribar 50% a cikin kudaden shiga na tallace-tallace daga Freesnius na likita.

Ckd-hade Pruritus (Ckd-Ap) babban Pruritus ne ke faruwa tare da babban mita da ƙarfi a cikin marasa lafiya masu CkD sun yi fama da cututtukan fata. Pruritus yana faruwa a cikin kusan 60% -70% na marasa lafiya da ke karɓar diantalsis, wanda ya haifar da ingancin rayuwa (misali, ingancin bacci) kuma yana da alaƙa da baƙin ciki. Babu wani ingantaccen magani ga Pruritus Ckd da Ckd kafin, da kuma amincewar frifalinfalin yana taimakawa wajen magance babbar damar samun damar jin lafiya. Wannan yardar ta dogara ne da gwaji na Pivotal biyu a cikin NDA Fasa.

Ba da daɗewa ba, kyakkyawan labari ya fito ne daga karatun asibiti na Dishalin a Japan: 2022-10, Pharidi Pharidi Pharma da Kissey ya sanar da cewa jakar ta Mariman don jabu a cikin marasa lafiya na Hodi. Lokaci na Asididdigar Tarihi na Asibitin Tarihi ana saduwa da ƙarshen ƙarshe. Marasa lafiya 178 sun sami makonni 6 na frifelikefalin ko placebo kuma sun shiga cikin nazarin tsawan shekaru 52. Babban matakin farko (Canza a Pruritus Questal Rating maki) da ƙarshen sakandare (Canza a cikin kungiyar Schorike a cikin kungiyar Shiratike a cikin kungiyar da ta fice da kungiyar Placebo

Frielikafalin shine aji na pepioid pepides. Dangane da wannan, Cibiyar Bincike ta Peptide ta yi nazarin wallafe-wallafen a kan peptigensiyoyi da dabarun optiid na ci gaba na yanzu.